Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 96
- Uncategorized
Canadian Cannabis Legalization Not Linked to Increase in Cannabis-Related Psychosis, Study Reports
Canadian researchers have found that the legalization of cannabis in Canada is not associated with higher rates of cannabis-related psychosis.
- Uncategorized
Alabama Cannabis Licences on Hold Again as Judge Issues Temporary Restraining Order
Alabama’s troubled medical cannabis licensing process has hit yet another roadblock as a judge has issued a temporary hold on issuing licences.
- Opinion
What’s in Store for the European Cannabis Industry in 2024 – Part 2
2024 is set to be the year of elections, with more than half of the global population (4.2m people) set to vote in over 70 elections around the world.
- Uncategorized
Cannabis Payments Processor Seeks $500m in Damages as It Closes Doors
Georgia-based cannabis payments processor FP Omni Technologies is seeking $500m in damages as it announces that it is winding down operations.
- Uncategorized
US Cannabis Stocks Spike as DEA Confirms Cannabis Reclassification Review
The US Drug Enforcement Administration (DEA) has confirmed that it is conducting a review into the reclassification of cannabis, but has asserted its ‘final authority’ over the decision.
- Press releases
Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK
Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the first shipment and launch of two leading cannabis brands in the United Kingdom (UK).
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 3
You can read part 1 of our Looking Ahead series here. Bryan Gerber – Founder & CEO, HARA Supply In preparation for 2024, cannabis operators are seeking to further cut costs and prioritize efficiency across the supply chain.
- Opinion
What’s in Store for the European Cannabis Industry in 2024 – Part 1
2023 was a year in which Germany, the European Union’s most populous country which has (in various forms) promised to legalise adult-use cannabis, continued to take the air out of the room and dictate much of the discourse around European cannabis.
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 2
You can read part 1 of our Looking Ahead series here. David Goubert, President & CEO, AYR Wellness MSOs will be focusing on the financial health of their companies, prioritizing cash flow generation and fostering leaner, more efficient operations.
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 1
2023 has been a significant year for cannabis across North America.
- Medical
Ukraine Makes ‘Historic Decision’ to Legalise Medical Cannabis
Ukraine has officially voted to legalise medical cannabis in what its Health Minister described as a ‘great victory for humanity and the beginning of a long journey’.
- Markets & Stocks
European Cannabis Stocks in 2023, MGC’s ArtemiC Approved in Saudi Arabia, & Panaxia Stock Skyrockets
European cannabis stocks in 2023 2023 has been perhaps the hardest financial year to date for the emerging European cannabis sector.










